STOCK TITAN
  1. Home
  2. Sec-filings
  3. ICUI
  4. [Form 4] ICU MEDICAL INC/DE Insider Trading Activity

ICU Medical (ICUI) director sells 2,424 shares, exercises options and receives RSU grant

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

ICU Medical director David C. Greenberg reported a mix of option exercises, stock sales, and equity awards. On May 12, 2026, he exercised options for 2,424 shares of common stock at $101.06 per share and sold 2,424 shares at $122.91 per share, leaving 7,960 shares held directly.

On May 13, 2026, 1,254 Restricted Stock Units vested into common stock, increasing his direct holdings to 9,214 shares. He also received a new grant of 1,475 Restricted Stock Units, which have no purchase or exercise price and will vest on the grant anniversary or the next annual stockholder meeting, whichever comes first.

Positive

  • None.

Negative

  • None.
Insider Greenberg David C.
Role null
Sold 2,424 shs ($298K)
Type Security Shares Price Value
Exercise Common Stock 1,254 $0.00 --
Grant/Award Common Stock 1,475 $0.00 --
Exercise Common Stock 1,254 $0.00 --
Exercise Non-Qualified Stock Option (right to buy) 2,424 $0.00 --
Exercise Common Stock 2,424 $101.06 $245K
Sale Common Stock 2,424 $122.91 $298K
Holdings After Transaction: Common Stock — 0 shares (Direct, null); Non-Qualified Stock Option (right to buy) — 0 shares (Direct, null)
Footnotes (1)
  1. All shares sold were at the exact price disclosed. These securities are Restricted Stock Units. There is neither a purchase price nor an exercise price for the Restricted Stock Units. These awards vest on the anniversary date of the date of the grant or the following annual stockholder meeting, whichever occurs first.
Shares sold 2,424 shares Open-market sale at $122.91 on May 12, 2026
Sale price $122.91/share Common stock sale of 2,424 shares on May 12, 2026
Options exercised 2,424 shares Non-qualified stock option exercise at $101.06/share
Option exercise price $101.06/share Non-derivative exercise into 2,424 common shares
RSUs vested 1,254 units Restricted Stock Units converting into common stock on May 13, 2026
New RSU grant 1,475 units Restricted Stock Unit award on May 13, 2026
Shares held after transactions 9,214 shares Common stock directly owned following May 13, 2026 activity
Non-Qualified Stock Option (right to buy) financial
"security_title": "Non-Qualified Stock Option (right to buy)""
Restricted Stock Units financial
"These securities are Restricted Stock Units."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Exercise or conversion of derivative security financial
"transaction_code_description": "Exercise or conversion of derivative security""
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Greenberg David C.
(Last)(First)(Middle)
951 CALLE AMANECER
(Street)
SAN CLEMENTE CALIFORNIA 92673
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
ICU MEDICAL INC/DE [ ICUI ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/13/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/12/2026M2,424A$101.0610,384D
Common Stock05/12/2026S2,424D$122.91(1)7,960D
Common Stock(2)05/13/2026M1,254A$09,214D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Non-Qualified Stock Option (right to buy)$101.0605/12/2026M2,42405/16/201705/16/2026Common Stock2,424$00D
Common Stock(2)$0(3)05/13/2026M1,25405/13/2026(4)05/13/2026Common Stock1,254$00D
Common Stock(2)$0(3)05/13/2026A1,47505/13/2027(4)05/13/2027Common Stock1,475$01,475D
Explanation of Responses:
1. All shares sold were at the exact price disclosed.
2. These securities are Restricted Stock Units.
3. There is neither a purchase price nor an exercise price for the Restricted Stock Units.
4. These awards vest on the anniversary date of the date of the grant or the following annual stockholder meeting, whichever occurs first.
Paula Darbyshire, Attorney-in-fact For: David C. Greenberg05/13/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did ICUI director David C. Greenberg report?

David C. Greenberg reported option exercises, an open-market sale, and equity awards. He exercised options for 2,424 ICU Medical shares, sold 2,424 shares, had 1,254 Restricted Stock Units vest into stock, and received a new grant of 1,475 Restricted Stock Units.

How many ICU Medical (ICUI) shares did the director sell and at what price?

Greenberg sold 2,424 shares of ICU Medical common stock at $122.91 per share. This was an open-market or private transaction sale, with the filing noting that all shares were sold at the exact disclosed price, reflecting a single-price trade.

What options did ICUI director David C. Greenberg exercise in this Form 4?

He exercised options for 2,424 shares of ICU Medical common stock at $101.06 per share. These options were represented as a non-qualified stock option, right to buy 2,424 underlying shares, which were fully exercised, leaving no remaining balance in that option grant.

What Restricted Stock Unit activity did ICUI report for the director?

The filing shows 1,254 Restricted Stock Units vesting into ICU Medical common stock and a new award of 1,475 Restricted Stock Units. The RSUs have no purchase or exercise price and vest on the grant anniversary or the next annual stockholder meeting, whichever occurs first.

How many ICU Medical (ICUI) shares does the director hold after these transactions?

After the reported transactions, Greenberg directly holds 9,214 shares of ICU Medical common stock. This figure reflects his position after exercising options, selling 2,424 shares at $122.91, and the vesting of 1,254 Restricted Stock Units into additional common shares.

Do the ICU Medical Restricted Stock Units in this Form 4 have an exercise price?

The Restricted Stock Units reported for Greenberg do not have a purchase or exercise price. Footnotes clarify there is neither a purchase price nor an exercise price for these RSUs, which convert into ICU Medical common stock upon vesting according to the award’s vesting schedule.